Avation Medical raises $22M+ to launch closed-loop wearable neuromodulation tech for overactive bladder treatment 2/5/2024 Category: INVESTMENTS
Episode 1 of Stories Behind the Change the first podcast by Angelini Industries spotlights our portfolio company Serenis 2/1/2024 Category: FEATURED IN
COUR Pharmaceuticals Secures $105 Million in Series A financing to advance first-in-class therapies to reprogram the immune system 1/30/2024 Category: INVESTMENTS
Noctrix Health, Inc. secures $40 Million Series C financing to commercialize novel device treatment for Restless Legs Syndrome (RLS) 1/16/2024 Category: INVESTMENTS
Wired Italia unveils Angelini Ventures' strategy: leading AI-driven health-tech innovation for the global future of care 1/11/2024 Category: FEATURED IN
Freya Biosciences secures $38 Million funding in one of the largest Series A raises to advance women’s reproductive immunotherapies 12/12/2023 Category: INVESTMENTS
Angelini Ventures